Agile Therapeutics
AGRX
#10310
Rank
โ‚ฌ8.89 M
Marketcap
1,29ย โ‚ฌ
Share price
0.00%
Change (1 day)
273.37%
Change (1 year)

EPS for Agile Therapeutics (AGRX)

EPS in 2024 (TTM): -3,58ย โ‚ฌ

According to Agile Therapeutics 's latest financial reports the company's current EPS (TTM) is -3,30ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -202,19ย โ‚ฌ an increase over its 2021 EPS that were of -1.331ย โ‚ฌ.

EPS history for Agile Therapeutics from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-3,58ย โ‚ฌ
2022-202,19ย โ‚ฌ-84.81%
2021-1.331ย โ‚ฌ30%
2020-1.024ย โ‚ฌ53.85%
2019-665,50ย โ‚ฌ-32.76%
2018-989,71ย โ‚ฌ
2016-1.723ย โ‚ฌ-26.28%
2015-2.338ย โ‚ฌ21.79%
2014-1.919ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
TherapeuticsMD
TXMD
-0,04266ย โ‚ฌ-98.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
0,29ย โ‚ฌ-108.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
8,91ย โ‚ฌ-369.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6,48ย โ‚ฌ-296.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1,47ย โ‚ฌ-144.44%๐Ÿ‡บ๐Ÿ‡ธ USA